Clinical Trials Browser

Phase 1/2 × Terminated × Disease × Clear all

NCT05348889 2025-02-13

First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Disease, Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma